Arable croplands are a significant source of nitrous oxide (NO) emissions, largely due to nitrogen (N) fertilizer applications to support crop production. Nevertheless, there is limited research on the NO dynamics from canola-wheat rotations in the semi-arid northern Prairies, an important agricultural region. Here, we present micrometeorological NO fluxes measured from January 2021 to April 2024 in Saskatchewan, Canada, to evaluate the impact of N fertilizer management on the year-round NO emissions from a canola-wheat rotation.
View Article and Find Full Text PDFCrop production has a large impact on the nitrogen (N) cycle, with consequences to climate, environment, and public health. Designing better N management will require indicators that accurately reflect the complexities of N cycling and provide biological meaning. Nitrogen use efficiency (NUE) is an established metric used to benchmark N management.
View Article and Find Full Text PDFThe protein chemerin (tazarotene-induced gene, TIG2; RARRES2) is a relatively new adipokine. Many studies support that circulating chemerin levels associate strongly and positively with body mass index, visceral fat, and blood pressure. Here, we focus on the specific relationship of chemerin and blood pressure with the goal of understanding whether and how chemerin drives (pathological) changes in blood pressure such that it could be interfered with therapeutically.
View Article and Find Full Text PDFSince chemerin's identification as an adipokine, it has been associated with a number of human diseases including diabetes and obesity. However, the basic scientific foundation for these clinical determinations is still lacking. Fibroblastic mouse 3T3 cells are unable to develop lipid droplets if chemerin is not present.
View Article and Find Full Text PDFChemerin is a contractile adipokine, produced in liver and fat, and removal of the protein by antisense oligonucleotides (ASO) lowers blood pressure in the normal Sprague Dawley rat. In humans, chemerin is positively associated with blood pressure and obesity so we hypothesized that in a model of hypertension derived from high-fat (HF) feeding, the chemerin ASO would reduce blood pressure more than a high-salt (HS) model. Male Dahl S rats were given a HF (60% kcal fat; age 3-24 wk) or HS diet (4% salt; age 20-24 wk to match age and blood pressure of HF animals).
View Article and Find Full Text PDF